Achieve Life Sciences, Inc.
NASDAQ•ACHV
CEO: Mr. Thomas B. King M.B.A.
Sector: Healthcare
Industry: Biotechnology
Listing Date: 1995-10-12
Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes cytisinicline for smoking cessation and nicotine addiction. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license and supply agreement with Sopharma AD and University of Bristol Achieve Life Sciences, Inc. is based in Vancouver, Canada.
Contact Information
1040 West Georgia Street, Suite 1030, Vancouver, BC, V6E 4H1, Canada
604-210-2217
Market Cap
$566.68M
P/E (TTM)
-5.7
24.5
Dividend Yield
--
52W High
$6.16
52W Low
$2.00
52W Range
Rank66Top 96.8%
1.5
F-Score
Modified Piotroski Analysis
Based on 10-year fundamentals
Weak • 1.5 / 9 points
Scoring Range (0-9)
8-9: Excellent Value
6-7: Strong Fundamentals
4-5: Average Quality
0-3: Weak Performance
Data Period: 2016-2025
Deep Research
Financials
Earnings Calls
Reports
News
Income Statement
Balance Sheet
Cash Flow Statement
Ratios
% Chg.
Income Statement | LTM |
|---|
No Data